Autopsy report · NCT03763708
SCS Research Study
Cause of deathFunding or business
“Business temporarily suspended study January 2023 with intent to include additional cohorts in future. For business reasons, study terminated April 2024.”
Life of this trial
- Ran for about 4 years 1 month before it stopped.
- 100 participants enrolled.
- Results were posted on the registry 2 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- MedtronicNeuro
- Sponsor type
- Industry
- Conditions
- Limb Pain; Trunk Pain
- Interventions
- Spinal Cord Stimulation
- Participants
- 100
- Sites
- 9
- Countries
- United States
Trials that died the same way
- Emory Latino Diabetes Education Program
“Enrollment and study activities were suspended in March 2020 due to the COVID-19 pandemic and re-opening the study was delayed pending additional funding. The study was ultimately terminated in January of 2026 due to lack of funding.” - Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
“Study suspended in October 2017 and terminated April 17, 2018 after decision to discontinue the study drug development” - Premotor Cortex: A New Target for Stroke Motor Rehabilitation
“Study was suspended pending additional funding to continue participant recruitment and was ultimately terminated in 2024.” - Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
“Study terminated for business reasons” - Norwegian Adenomyosis Study III: Peristalsis
“Study was suspended due to organisational difficulties.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.